Studies involving sample source:Spinal cord

Study ID Study Title Species Institute
ST000792Large Untargeted Profiling of Myelin to Enhance Recovery of Function after SCIMouseMayo Clinic
ST000793Targeted FFA Composition of Myelin to Enhance Recovery of Function after SCIMouseMayo Clinic
ST000794Targeted NEFA Panel of Myelin to Enhance Recovery of Function after SCIMouseMayo Clinic
ST000795Targeted Cholesterol Profiling of Myelin to Enhance Recovery of Function after SCIMouseMayo Clinic
ST000796Targeted Sphingolipids Panel of Myelin to Enhance Recovery of Function after SCIMouseMayo Clinic
ST000797Targeted Galactosyl Sphingolipids Concentrations of Myelin to Enhance Recovery of Function after SCIMouseMayo Clinic
ST000798Targeted Sphinomyelin Panel of Myelin to Enhance Recovery of Function after SCIMouseMayo Clinic
ST000799Targeted TCA Panel of Myelin to Enhance Recovery of Function after SCIMouseMayo Clinic
ST000848Targeting Myelin NEFA of Kallikrein 6 Signals through PAR1 and PAR2 to Enchance Recovery of Function after SCIMouseMayo Clinic
ST000849Targeting Myelin FFA Compostion of Kallikrein 6 Signals through PAR1 and PAR2 to Enchance Recovery of Function after SCIMouseMayo Clinic
ST000850Targeting Myelin Cholesterol of Kallikrein 6 Signals through PAR1 and PAR2 to Enchance Recovery of Function after SCIMouseMayo Clinic
ST000851Targeting Myelin Sphingolipids of Kallikrein 6 Signals through PAR1 and PAR2 to Enchance Recovery of Function after SCIMouseMayo Clinic
ST000852Targeting Myelin Galactosyl Sphingolipids of Kallikrein 6 Signals through PAR1 and PAR2 to Enchance Recovery of Function after SCIMouseMayo Clinic
ST000853Targeting Myelin Sphinomyelin concentrations of Kallikrein 6 Signals through PAR1 and PAR2 to Enchance Recovery of Function after SCIMouseMayo Clinic
ST000854Targeted FFA Composition in Kallikrein 6 Mice after SCIMouseMayo Clinic
ST000856Targeted NEFA in Kallikrein 6 Mice after SCIMouseMayo Clinic
ST000857Targeted Cholesterol Profiling of Myelin to Enhance Recovery of Function after SCI. Second Set of SamplesMouseMayo Clinic
ST000858Targeted Sphingolipids in Kallikrein 6 Mice after SCIMouseMayo Clinic
ST000859Targeted Galactosyl Sphingolipid Concentration in Kallikrein 6 Mice after SCIMouseMayo Clinic
ST000860Targeted Sphingomyelin Concentrations in Kallikrein 6 Mice after SCIMouseMayo Clinic
ST000861Targeting Myelin NEFA in PAR1 and PAR2 Mice after SCIMouseMayo Clinic
ST000862Targeting Myelin FFA Compostion in PAR1 and PAR2 Mice after SCIMouseMayo Clinic
ST000863Targeting Myelin Cholesterol in PAR1 and PAR2 Mice after SCIMouseMayo Clinic
ST000864Targeting Myelin Ceramides in PAR1 and PAR2 Mice after SCIMouseMayo Clinic
ST000866Large Untargeted Profiling in PAR1 and PAR2 Mice after SCIMouseMayo Clinic
ST000869Large Untargeted Profiling in Kallikrein 6 Mice after SCIMouseMayo Clinic
ST002958Lipidomic analysis of demyelination and remyelination in the Plp1-iCKO-Myrf mouse model of demyelinationMouseUniversity of Kansas
ST003193Metabolomics study on frozen tissue derived from the tumor and adjacent non-malignant liver tissue (NML) of patient afflicted with fibrolamellar carinoma (FLC)HumanCornell University

Return to search page
  logo